Report by
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
If your report is poison related call
1-800-222-1222
for a free consultation with a live medical poisoning expert
Visit our learn pages for more helpful information or, email us:
support@safelyhq.com
Goodbye! and best wishes in your recovery
Art gallery
Updated: April 1, 2021 12:00 PM
Covid-19 OSHA Complaint, Michigan Made Houghton, 300 Sheldon Ave, HOUGHTON, MI, 49931, USA
Michigan Made Houghton, 300 Sheldon Ave, HOUGHTON, MI, 49931, USA
April 1, 2021 12:00 PM
“'- An employee was terminated for asking a customer to correctly wear a mask over the mouth and nose, presumably because the employee did not have the authority to enforce Executive Order 2020-153. - Many customers enter the store without a mask or wear the mask incorrectly. - Employees interact wit... See Moreh customers with less than six feet of separation. - Employees are not provided with training on how to deal with customers that do not wear a mask into the store.
Source: Osha.gov | Receipt Date: 2020-08-24 See Less”
Helpful
Covid-19 OSHA Complaint, Papworth Photographic, 1065 Glades Road, Gatlinburg, TN 37738, USA
Papworth Photographic, 1065 Glades Road, Gatlinburg, TN 37738, USA
April 1, 2021 12:00 PM
“Employer is not taking steps to protect employees from SARS-COV-2(COVID-19).
Alleged Hazards: 1, Employees Exposed: 4
Source: Osha.gov | Receipt Date: 2021-01-25 See Less”
Helpful
Covid-19 OSHA Complaint, Besco Electric Supply Co, 711 South 14th Street, LEESBURG, FL, 34748, USA
Besco Electric Supply Co, 711 South 14th Street, LEESBURG, FL, 34748, USA
February 24, 2021 12:00 PM
“1) Employees are exposed to COVID-19 from employees and customers not being required to wear facemasks. 2) Employees are exposed to unsanitary work environment from employer not having pest control in place and allowing rats and mice to infest in kitchen and stock room.
Source: Osha.gov | Receipt... See MoreDate: 2021-01-14 See Less”
Helpful
Covid-19 OSHA Complaint, Julia Rickards and Dan Rickards, 303 W Hood Ave, SISTERS, OR, 97759, USA
Julia Rickards and Dan Rickards, 303 W Hood Ave, SISTERS, OR, 97759, USA
February 24, 2021 12:00 PM
“Serious
Alleged Hazards: 1,
Source: Osha.gov | Receipt Date: 2021-01-04 See Less”
Helpful
Covid-19 OSHA Complaint, Hot Yoga Northeast LLC, 1301 NE Alberta St, PORTLAND, OR, 97211, USA
Hot Yoga Northeast LLC, 1301 NE Alberta St, PORTLAND, OR, 97211, USA
February 17, 2021 12:00 PM
“Serious
Alleged Hazards: 1,
Source: Osha.gov | Receipt Date: 2020-12-10 See Less”
Helpful
Covid-19 OSHA Complaint, Calamity Jane's Tattoo, 803 North Avenue, GRAND JUNCTION, CO, 81501, USA
Calamity Jane's Tattoo, 803 North Avenue, GRAND JUNCTION, CO, 81501, USA
February 3, 2021 12:00 PM
“1. Employees are potentially exposed to the virus that causes COVID-19. The employer has not provided personal protective equipment. Contrary to Section 5(a)(1) of the OSH Act. 2. Employees are potentially exposed to the virus that causes COVID-19. The employer has not provided training on methods t... See Moreo prevent or reduce transmission. Contrary to Section 5(a)(1) of the OSH Act.
Alleged Hazards: 2, Employees Exposed: 2
Source: Osha.gov | Receipt Date: 2021-01-04 See Less”
Helpful
Covid-19 OSHA Complaint, Montserrat College of Art, 23 Essex Street, BEVERLY, MA, 01915, USA
Montserrat College of Art, 23 Essex Street, BEVERLY, MA, 01915, USA
February 2, 2021 12:00 PM
“1. Employees are not wearing masks, and the employer is not conducting sanitizing in regard to COVID-19. 2. Bathrooms on campus are not maintained in a sanitary condition.
Alleged Hazards: 3, Employees Exposed: 1
Source: Osha.gov | Receipt Date: 2020-12-03 See Less”
Helpful
15 individuals tested positive for Covid-19, Meow Wolf Denver, 1338 1st St, Denver, CO 80204
Meow Wolf Denver, 1338 1st St, Denver, CO 80204
January 7, 2021 12:00 PM
“15 individuals at Meow Wolf in Denver county tested positive for Covid-19. The outbreak began on 11/19/20
Source: colorado.gov See Less”
Helpful
An Employee test positive for Covid-19, Tamarack: The Best Of West Virginia, 1 Tamarack Pl, Beckley, WV 25801, United States
Tamarack: The Best Of West Virginia, 1 Tamarack Pl, Beckley, WV 25801, United States
November 11, 2020 12:00 PM
“An employee at Tamarack: The Best Of West Virginia located on 1 Tamarack Pl in Beckley recently tested positive for Covid-19
Source: wdtv.com See Less”
Helpful
Employee tested positive for Covid-19, Tamarack: The Best Of West Virginia, Tamarack Place, Beckley, W.Va, USA
Tamarack: The Best Of West Virginia, Tamarack Place, Beckley, W.Va, USA
November 2, 2020 12:00 PM
“An employee at the Tamarack arts and crafts facility recently tested positive for Covid-19
Source: wchstv.com See Less”
Helpful
Recent Interesting Reports
April 1, 2021 12:02 PM
“Company name: NANA Collection LLC
Brand name: PremierZen Platinum 5000, Triple SupremeZen Gold 3500
Product recalled: Dietary Supplement for male sexual enhancement
Reason of the recall: Undeclared Sildenafil and Tadalafil
FDA Recall date: April 01, 2021
Recall details: NANA Collection LLC is v... See Moreoluntarily recalling all lots of PremierZen Platinum 5000 and Triple SupremeZen Gold 3500 to the consumer level. FDA analysis has found the PremierZen Platinum 5000 to contain undeclared Tadalafil and Triple SupremeZen 3500 to contain undeclared Tadalafil and Sildenafil. Sildenafil and Tadalafil are ingredients known as phosphodiesterase (PDE-5) inhibitors found in FDA approved products for the treatment of male erectile dysfunction.
The presence of Tadalafil and Sildenafil in PremierZen Platinum 5000 & Triple SupremeZen Gold 3500 renders them unapproved drugs for which safety and efficacy have not been established and, therefore, subject to recall. Consumers with underlying medical issues who take PremierZen Platinum 5000 with Tadalafil and Triple SupremeZen Gold 3500 with undeclared Tadalafil and Sildenafil may experience serious health risks. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening.
Consumers with diabetes, high blood pressure, or heart disease often take nitrates. To date, NANA Collection LLC has not received any reports of adverse events related to this recall. This tainted PremierZen Platinum 5000 and Triple SupremeZen Gold 3500 are marketed as dietary supplements for male sexual enhancement and are packaged in paper packaging with a pill blister, 1 capsule per package. The affected PremierZen Platinum 5000 and Triple SupremeZen Gold 3500 lots include all lot numbers to include GATCO 01671, GATCO 1805 with expiration date 12/30/2024. The product can be identified by the word ZEN stamped on the capsule along with PremierZen and Triple SurpremeZen written on the packaging.
PremierZen Platinum 5000 and Triple SupremeZen Gold 3500 were distributed via internet and fulfilled by amazon at www.amazon.com nationwide in the USA. On December 17, 2020, FDA issued a press release that warned consumers to avoid certain products found on Amazon, eBay and other retailers due to hidden and potentially dangerous drug ingredients. It also encouraged online marketplaces to ensure these products are not sold on their platforms. NANA Collection LLC is notifying its customers by this press announcement and via email of this recall.
Consumers that have PremierZen Platinum 5000 and Triple SupremeZen Gold 3500 which are being recalled should discard the product. Consumers with questions regarding this recall can contact NANA Collection LLC by 201-773-8545 or nanastyle2014@gmail.com on Monday through Friday from 9am to 5pm, eastern time.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online by regular mail or by fax. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Check the full recall details on fda.gov
Source: FDA See Less”
Helpful
Johnson&Johnson vaccine, Kansas City, KS, USA
Kansas City, KS, USA
April 9, 2021 3:15 PM
“I got the j&j vac at 1:00pm its been 1 hour so far only a slight tingling on vaccination spot other than that nothing big hoping for the best See Less”
Helpful
1 person found this review helpful
April 6, 2021 10:19 PM
“Got the JnJ vaccine Monday morning 4/5/21 at Wegman’s Bridgewater. Other than my arm being a little sore I have no side effects at all. No head aches, no fevers, nothing! SIDE NOTE: I took a COVID test a few days before to confirm I was COVID free before getting vaccinated. I was on Claritin from th... See Moree night before because allergy season has officially started. I didn’t want the Moderna or Pfizer... not a fan of the lipid MRNA. - Stay Safe guys! See Less”
Helpful
After first Moderna shot, Sebastopol, CA, USA
Symptoms: Other
Body Ache
Soreness
Sebastopol, CA, USA
March 26, 2021 5:51 PM
“Sore arm first night, much like a flu shot. In subsequent days had achy lymph nodes in armpit, neck and upper chest. No big deal, just rather odd. 9 days after shot I woke with first Atrial fib in almost 6 weeks (had second Cardiac ablation last summer that we hoped would "fix" it). I had Afib episo... See Moredes next two nights, decreasing in intensity, but certainly requiring meds and monitoring. Since been diagnosed with Afib bit over 2 years ago had never had it multiple days in a row before.
Since then, every days it's less problematic. Now just an hour of feeling a tad funky in the afternoons.Asked my cardiologist if he'd had other patients with similar reactions and he said "yes", but mostly after second vaccination. Seems as if the inflammation that's triggered by vaccine as body responds and creates antibodies to virus, triggers "twitchy" susceptible heart into freaking out (my language, not his!) Makes me rather dread how I"m going to feel next week after second shot, But will certainly not deter me to get fully covered. See Less”
Helpful
1 person found this review helpful
March 31, 2021 10:00 AM
“Company name: Ummzy LLC
Brand name: Thumbs Up 7, Shogun, Krazy Night
Product recalled: Dietary Supplement for male sexual enhancement
Reason of the recall: Undeclared Sildenafil, Tadalafil, Vardenafil
FDA Recall date: March 31, 2021
Recall details: Palisades Park, NJ, Ummzy LLC is voluntarily r... See Moreecalling all lots of Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Night capsules to consumer level. FDA analysis has found the product to contain undeclared tadalafil sildenafil & Vardenafil. Tadalafil, Sildenafil & Vardenafil are ingredients known as phosphodiesterase (PD-5) inhibitors found in FDA approved products for the treatment of male erectile dysfunction. The presence of Tadalafil Sldenafil & Vardenafilin Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Night capsules makes them unapproved new drugs for which the safety and efficacy have not been established and, therefore subject to recall.
Consumers with underlying medical issues who take Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Night capsules with undeclared Tadalafil Sildenafil & Vardenafil may experience serious health risks. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening.
Consumers with diabetes, high blood pressure, or heart disease often take nitrates. To date, Ummzy LLChas not received any reports of adverse events related to this recall. This tainted product is marketed as a dietary supplement for male sexual enhancement and is packaged in blister foil sheets in a box containing 10 capsules. The affected lot numbers of Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Night includes all lots. Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Night was distributed nationwide in the USA via internet and fulfilled by amazon at www.amazon.com.
On December 17, 2020, FDA issued a press release that warned consumers to avoid certain products found on Amazon, eBay and other retailers due to hidden and potentially dangerous drug ingredients. It also encouraged online marketplaces to ensure these products are not sold on their platforms. Ummzy LLC is notifying its customers by this press announcement and via e-mail of this recall.
Consumers that have Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Night, which is being recalled should stop using and destroy them. Consumers with questions regarding this recall can contact Ummzy LLC by phone at 201-416-9325 Monday to Friday from 9AM to 5PM or e-mail ysknabe75@gmail.com. For more information, please visit www.ummzyllc.com.
Consumers should contact their physicians or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Check the full recall details on fda.gov
Source: FDA See Less”
Helpful
Blackcass.com chainsaw, scam, Denver, CO, USA
Denver, CO, USA
March 23, 2021 5:59 PM
“All I received was the chain and straps not the chain saw how can I get my money back? I am 73 and got cheated out of $29.99 plus tax for a chain saw when all I received was a chain and I want my money back See Less”
Helpful
1 person found this review helpful
March 25, 2021 11:00 AM
“Company name: Zydus Pharmaceuticals Inc.
Brand name: Zydus Pharmaceuticals
Product recalled: Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials
Reason of the recall: Due to Crystalization
FDA Recall date: March 25, 2021
Recall details: Pennington, NJ, Zydus Pharmaceuticals (USA) Inc. i... See Mores voluntarily recalling four lots of Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials, to the Hospital/User level after receiving several complaints of crystallization in vials.
Administration of crystalized Acyclovir Sodium Injection, 50 mg/mL has a potential of life-threatening adverse consequences including injection site inflammation of a vein and local reactions, damage and/or obstruction of blood vessels, which could induce clots, particularly in the lungs, the passage of the particulate matter into the bloodstream may lead to clots resulting in stroke, heart attack, decreased liver or kidney function or death of tissues or cells.
To date, Zydus Pharmaceuticals (USA) Inc. has not received any reports of adverse events related to this product recall. Acyclovir Sodium Injection, 50 mg/mL is indicated for the treatment of herpes simplex infections in immunocompromised patients, severe initial clinical episodes of herpes genitalis in immuno-competent patients, herpes simplex encephalitis, neonatal herpes simplex virus infection and varicella-zoster (shingles) infections in immunocompromised patients.
The product is packaged in single-dose glass vials and was distributed nationwide in the USA to Cardinal Health, Amerisourcebergen Drug Corporation and Morris & Dickson Company LLC. The affected Acyclovir Sodium Injection, 50 mg/mL lots include the following lot numbers and expiration dates:
- Acyclovir Sodium Injection, 50 mg/mL, 20 mL. Carton NDC Number: 68382-049-10. Vial NDC Number: 68382-049-01. Lot Number: L000155. Expiry Date: Dec 2021. Pack Size: 10x20 mL, Single-Dose Vial pack.
- Acyclovir Sodium Injection, 50 mg/mL, 20 mL. Carton NDC Number: 68382-049-10. Vial NDC Number: 68382-049-01. Lot Number: L000156. Expiry Date: Jan 2022. Pack Size: 10x20 mL, Single-Dose Vial pack.
- Acyclovir Sodium Injection 50 mg/mL, 10 mL. Carton NDC Number: 68382-048-10. Vial NDC Number: 68382-048-01. Lot Number: L000126. Expiry Date: Dec 2021. Pack Size: 10x10 mL, Single-Dose Vial pack.
- Acyclovir Sodium Injection 50 mg/mL, 10 mL. Carton NDC Number: 68382-048-10. Vial NDC Number: 68382-048-01. Lot Number: L000127. Expiry Date: Dec 2021. Pack Size: 10x10 mL, Single-Dose Vial pack.
Zydus Pharmaceuticals (USA) Inc. has notified its distributors and customers by email and FedEx overnight courier service and is arranging for the return of all recalled Acyclovir Sodium Injection, 50 mg/mL lots. Hospitals that have the product which is being recalled should stop using it immediately and call our recall coordinating center at 1-855-671-5023 [Call: 1-855-671-5023] Monday – Friday (excluding holidays), 9:00 am to 5:00 pm EST.
Consumers with questions regarding this recall can contact Zydus Pharmaceuticals (USA) Inc. by phone: 1-877-993-8779 [Call: 1-877-993-8779] or by email: medicalaffairs@zydususa.com Monday – Friday (excluding holidays), 9:00 am to 5:00 pm EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Check the full recall details on fda.gov
Source: FDA See Less”
Helpful
1 person found this review helpful
I am reporting Pfizer vaccine, Lecompte, LA 71346, USA
Symptoms: Other
Headache
Lecompte, LA 71346, USA
March 22, 2021 7:48 PM
“In February I received my 1st dose of Pfizer vaccine and I did get a headache.. yet it was the second dose on March 3 that made me go to the doctor and found that that vaccine has cause me to have high high blood pressure! My numbers doubled and I have not recovered. Now on high blood pressure me... See Moreds. The doctor says I have fluid built up around my heart and palpitations that are driving me to unhappy days.
Letting you know. . See Less”
Helpful
5 people found this review helpful
March 31, 2021 8:00 PM
“Company name: Apotex Corp.
Brand name: Apotex Corp.
Product recalled: Guanfacine Extended-Release Tablets 2mg
Reason of the recall: Trace amounts of Quetiapine Fumarate
FDA Recall date: March 31, 2021
Recall details: Weston, Florida, Apotex Corp is voluntarily recalling three (3) lots of Guanfa... See Morecine Extended-Release Tablets 2mg to the consumer level due to trace amounts of Quetiapine Fumarate in one lot RX1663. Out of an abundance of caution, lots RX1662 and RX1664 are also included in the scope of this voluntary recall, as they were manufactured in the same campaign as lot RX1663.
Risk Statement: Administration of Guanfacine Extended-Release Tablets containing trace amounts of Quetiapine Fumarate to a patient can result in the possibility of hypersensitivity reaction and may potentially have additive effects in lowering blood pressure, sleepiness/sedation, and dizziness. Pediatric patients, pregnant patients and older adults may be more likely to experience low blood pressure and dizziness if exposed to the defective product.
To date, Apotex Corp has not received any reports of adverse events related to this recall. Guanfacine is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and can be used with other stimulant medications. Quetiapine is indicated for the treatment of Schizophrenia and other serious mental disorders such as Bipolar disorder manic episodes, Bipolar disorder, and depressive episodes.
The affected Guanfacine Extended-Release Tablets can be identified by NDC numbers stated on label of the product. The lot number and Expiration date are located to the left side of the product description on the label besides the 2D barcode. The affected lots were distributed in the USA between December 22, 2020 to March 19, 2021.
- Guanfacine Extended-Release Tablets. Pack Size: 100 Tablets. Strength: 2 mg. NDC Number: 60505-3928-1. UPC Code: 3 60505 39281 0. Lot Number / Expiry Date: RX1662 / Nov-22 | RX1663 / Nov-22 | RX1664 / Nov-22
The three (3) affected lots of Guanfacine extended-release tablets were distributed by Apotex nationwide in the USA to Wholesalers, Distributors, Warehousing Chains, Independent Retail Pharmacy and Retail Buying Group. Apotex Corp is currently notifying its affected direct account Wholesalers, Distributors, Warehousing Chains, Independent Retail Pharmacy and Retail Buying Group, via mail (FedEx Standard Overnight) and is arranging for return of all recalled product.
Patients who have received either of the three impacted lots of Guanfacine Extended-Release Tablets or have questions regarding this recall should contact their pharmacy. Individuals should not interrupt their therapy due to this notice. They should immediately contact their health care provider for medical advice and return the impacted product to Inmar Rx Solutions by contacting at the numbers provided in this press release.
Wholesalers, Distributors, Warehousing Chains, Independent Retail Pharmacy and Retail Buying Group should return the recalled product to the place of purchase. Anyone with an existing inventory of the recalled product should quarantine the recalled lots immediately. Customers who purchased the impacted product directly from Apotex can call Inmar Rx Solutions at 1-855-697-4722 (9:00am – 5:00-pm, EST Monday thru Friday), to arrange for their return.
Consumers with the affected units of Guanfacine Extended-Release Tablets, can contact Inmar Rx Solutions (“Inmar”) at 1-855-697-4722, to receive a recall/return packet including the Recall Stock Response Form, or you may obtain this form clsnetlink.comExternal Link Disclaimer
Consumers with questions regarding this recall can contact Apotex Corp. by phone at 1-800-706-5575 (8:30am –5:00pm, EST Monday thru Friday) or email address UScustomerservice@Apotex.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Check the full recall details on fda.gov
Source: FDA See Less”
Helpful
April 2, 2021 8:00 PM
“Company name: A-S Medication Solutions, LLM
Brand name: A-S Medication Solutions, LLM
Product recalled: Acetaminophen Extra Strength 500 mg Tablets, 100 ct. bottles contained in Health Essentials Kits distributed by Humana
Reason of the recall: Products contain an incomplete prescription drug lab... See Moreel
FDA Recall date: April 02, 2021
Recall details: Libertyville, IL, A-S Medication Solutions, LLM (ASM) is voluntarily recalling 198,350 bottles of Acetaminophen Extra Strength 500 mg Tablets, 100 ct. bottles (NDC# 50090-5350-0) contained in Health Essentials Kits distributed by Humana to its members. See the photo below. This recall is being conducted to the consumer level. These over-the-counter (OTC) analgesic products contain an incomplete prescription drug label rather than the required OTC Drug Facts label.
Risk Statement: Use of acetaminophen could be potentially harmful if safety warnings contained on the OTC label are not observed including: liver damage if consumers exceed the recommended dose, combine use with excessive consumption of alcohol, or are allergic to the active ingredient. To date, the Company has not received any reports of adverse events related to this recall.
The product is used as a pain and fever reliever. The 100-count bottles labeled with NDC 50090-5350-0 are packaged in white plastic bottles contained in a clear plastic bag with other seasonal products labeled as a Health Essentials Kit. Distribution likely occurred between 1/14/21 and 3/15/21 nationwide in the USA. Expiration dates are either 7/31/22 or 8/31/22. The affected bottles that should be returned contain a short Rx drug label that lacks the full OTC Drug Facts chart.
ASM is also notifying its distributors and customers by mail and is arranging for return of all recalled products. Consumers and distributors that have this product which is being recalled should stop using it and return it in preaddressed return mailers that will be provided by ASM or the distributors.
Consumers with questions regarding this recall can contact ASM by telephone at 847.680.3515 x 236, from 9-5 p.m. CST, or e-mail at anel.figueroa@a-smeds.com. Consumers should contact their physician or healthcare provider if they experience any problems that may be related to taking or using this or any drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online.
- Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
NDC # 50090-5350-0 Lot #s 323206, 323207, 323208, 323209, 323210, 323211, 323212, 323213, 323214, 323215, 323216, 323218, 323219, 323220, 323222, 323223, 323224, 323238, 335353, 335354, 335355, 335356, 335358, 335359, 335360, 335361, 335362, 335363, 335364, 335365, 335366, 33536, 335368, 335369, 335370, 335371, 335372, 335373, 335374, 335375, 335376, 335377, 335395, and 352116.
Check the full recall details on fda.gov
Source: FDA See Less”
Helpful
1 person found this review helpful